FDA-Approved Drop XDEMVY Offers Targeted Relief for Demodex Blepharitis Patients, Modern Vision Solutions Reports

OMAHA, NE - January 22, 2026 - PRESSADVANTAGE - Modern Vision Solutions has announced the publication of a new article, ...
Medical News Today

What is the difference between a stye and blepharitis?

Blepharitis is a condition that causes inflammation of the eyelid. A person with blepharitis may experience swollen, irritated, and itchy eyelids. A stye is a painful lump that develops on the upper ...
The Indianapolis Star

Carrot LASIK & Eye Center Brings Relief to Patients with Blepharitis Using the Latest FDA-Approved Treatments

Blepharitis, a chronic condition that causes inflammation of the eyelids, affects millions of people across the United States. Despite being common, it is frequently underdiagnosed or mistaken for ...
standardmedia.co.ke

Managing Blepharitis: Causes and treatments

The treatment of blepharitis focuses on alleviating symptoms, addressing underlying causes, and preventing complications. [iStockphotos] Blepharitis is a common chronic condition that affects the ...
KRQE Blogs

Now Available – XDEMVY™ (lotilaner ophthalmic solution) 0.25%, the First and Only FDA Approved Treatment for Demodex Blepharitis

Demodex blepharitis impacts approximately 25 million eye care patients in the U.S. – or 1 out of every 12 adults. XDEMVY is indicated for all adult patients with Demodex blepharitis and is available ...
Hosted on MSN

Viatris Shares Dip After Blepharitis Treatment Fails to Hit Main Study Goal

Viatris Inc. (NASDAQ:VTRS) saw its stock drop 3.6% following news that its late-stage trial for MR-139, a potential treatment for blepharitis, did not achieve its primary endpoint. The Phase 3 study, ...
standardmedia.co.ke

Managing Blepharitis: Causes and treatments

For the best experience, please enable JavaScript in your browser settings. The treatment of blepharitis focuses on alleviating symptoms, addressing underlying causes ...